Kit for detecting respiratory viruses and application thereof
A respiratory tract and kit technology, applied in the field of respiratory virus detection kits, can solve the problems of false negatives, long virus time, complicated and expensive electron microscope detection methods, etc., and achieve the effect of accurate detection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Embodiment 1, preparation and use thereof for detecting the kit of respiratory tract virus
[0038] 1. Preparation of kits for detecting respiratory viruses
[0039] The kit for detecting respiratory virus provided by the present invention consists of the following:
[0040] 1. Constant temperature amplification buffer
[0041] The solvent of the constant temperature amplification buffer is water, and the solute and concentration are as follows: 200mM Tris-HCL (pH 8.0), 50mM DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl 2 , 450mM KCl, 15% by volume DMSO, 1M sorbitol, 20mM tetramethylammonium chloride.
[0042] 2. Constant temperature amplification enzyme solution
[0043] The solvent of the constant temperature amplification enzyme solution is water, and the solute and concentration are as follows: AMV reverse transcriptase 1U / μl, T7 RNA polymerase 5U / μl, ribonuclease H 0.5U / μl, pyrophosphatase 0.5U / μl, RNase inhibitor Agent 5U / μl, BSA 0.5μg / μl.
[0044] 3. A 24-chamber dis...
Embodiment 2
[0058] Example 2. Sensitivity and specificity analysis of the kit for detecting respiratory viruses
[0059] 1. Preparation of reference RNA nucleic acid
[0060] 1. Construction of plasmids containing viral target genes
[0061] (1) Plasmid containing influenza A virus NP target gene
[0062] Insert segment 1-1541 of the influenza A virus NP target gene sequence (Genbank number Sequence ID of the influenza A virus NP target gene sequence: gb|KM366530.1|, Update Date: 2014-9-27) into the pUC19 vector (product of Tiange Biochemical Company) between the multiple cloning sites EcoRⅤ to obtain the recombinant plasmid pUC19-InfA.
[0063] (2) Plasmids containing influenza A virus H1 subtype target genes
[0064] Segment 1-1698 of the target gene sequence of influenza A virus H1 subtype (Genbank number Sequence ID of the target gene sequence of influenza A virus H1 subtype: gb|GQ475727.1|, Update Date: 2009-8-19) It was inserted into the pUC19 vector (Tiange Biochemical Co., Ltd...
Embodiment 3
[0126] Embodiment 3, the detection of actual clinical sample
[0127] 1. Types of clinical samples
[0128] The clinical samples used in this example came from the nasopharyngeal swab samples collected by Shenzhen No. 3 Hospital (based on the principle of voluntariness of the collectors), and the collected swabs were stored in 3 mL of normal saline, a total of 560 cases.
[0129] 2. Extraction of viral nucleic acid in clinical samples
[0130] The kit used for the extraction of viral nucleic acid from clinical samples is QIAamp Viral RNA Mini Kit (Qiagen), and the extraction is performed as follows:
[0131] (1) Take 140 μl of physiological saline for storing clinical sample swabs in step 1 into a 1.5ml centrifuge tube;
[0132] (2) Add 560 μl Buffer AVL containing Carrier RNA mixture (i.e. 5.6 μl Carrier RNA mixture + 560 μl Buffer AVL to the centrifuge tube, vortex slightly for 15 seconds;
[0133] (3) After the transient centrifugation is completed, place it at room temp...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com